by Stellenbosch University South Africa Credit: Unsplash/CC0 Public Domain Two landmark clinical trials reported at the Union Conference in Paris showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB. The antibiotic levofloxacin safely reduced the risk of multidrug-resistant (MDR) tuberculosis (TB) disease in children by 56%,...
